Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases

  • Soler-Sáez, Irene
  • Alcida Karz
  • Hidalgo, Marta R.
  • Gómez-Cabañes, Borja
  • López-Cerdán, Adolfo
  • Català-Senent, José F.
  • Prutisto-Chang, Kylie
  • Eskow, Nicole M.
  • Izar, Benjamin
  • Redmer, Torben
  • Kumar, Swaminathan
  • Davis, Michael A.
  • Hernando, Eva
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Melanoma represents a critical clinical challenge owing to its unfavorable outcomes. This type of skin cancer exhibits unique adaptability to the brain microenvironment, but its underlying molecular mechanisms are poorly understood. Recent findings have suggested that melanoma brain metastases may share biological processes similar to those found in various neurodegenerative diseases. To further characterize melanoma brain metastasis development, we explore the relationship between the transcriptional profiles of melanoma brain metastases and the neurodegenerative diseases Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We take an in silico approach to unveil a neurodegenerative signature of melanoma brain metastases compared with those of melanoma nonbrain metastasis (53 dysregulated genes were enriched in 11 functional terms, such as associated terms to the extracellular matrix and development) and with those of nontumor-bearing brain controls (195 dysregulated genes, mostly involved in development and cell differentiation, chromatin remodeling and nucleosome organization, and translation). Two genes, ITGA10 and DNAJC6, emerged as key potential markers being dysregulated in both scenarios. Finally, we developed an open-source, user-friendly web tool (https://bioinfo.cipf.es/metafun-mbm/) that allows interactive exploration of the complete results., The authors thank the Principe Felipe Research Center for providing access to the cluster, cofunded by European Regional Development Funds to the Valencian Community 2014-2020. This research was supported and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019) , cofunded by ERDF, "A way to make Europe", PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033, and by European Regional Development Fund. IS-S is supported by a predoctoral grant FPU20/03544 funded by the Spanish Ministry of Universities. BG-C is supported by a PhD fellowship funded by the Spanish Association Against Cancer in Valencia (PRDVA234163GOME) . MAD is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the AIM at Melanoma Foundation, the National Institutes of Health/National Cancer Insititute P50CA221703, the American Cancer Society and the Melanoma Research Alliance, Cancer Fighters of Houston, the Anne and John Mendelsohn Chair for Cancer Research, and philanthropic contributions to the Melanoma Moon Shots Program of MD Anderson. We also thank the authors of the previous publications (PMID: 30787016; PMID: 35803246; PMID: 36435874) for their commitment to open science by depositing the data in public repositories, making the data available and reusable. FG-G is the guarantor of this work.